Efficient Differentiation of Postganglionic Sympathetic Neurons using Human Pluripotent Stem Cells under Feeder-free and Chemically Defined Culture Conditions
May 24th, 2020
15.1K views
In this protocol, we describe a stable, highly efficient differentiation strategy for the generation of postganglionic sympathetic neurons from human pluripotent stem cells. This model will make neurons available for the use of studies of multiple autonomic disorders.
Overview
This protocol describes a highly efficient method for generating postganglionic sympathetic neurons from human pluripotent stem cells. This model facilitates the study of various autonomic disorders.
Key Study Components
Area of Science
- Neuroscience
- Stem Cell Biology
- Autonomic Disorders
Background
- Sympathetic neurons play a crucial role in the autonomic nervous system.
- Human pluripotent stem cells can differentiate into various cell types.
- Understanding sympathetic neuron function is essential for addressing related disorders.
- Current methods for deriving these neurons may lack efficiency.
Purpose of Study
- To develop a reliable differentiation protocol for sympathetic neurons.
- To enable research on diseases affecting the sympathetic nervous system.
- To provide a scalable method for neuron generation.
Methods Used
- Derivation of sympathetic neurons from human pluripotent stem cells.
- Feeder-free culture conditions to enhance scalability.
- Assessment of neuronal activity within 20 days.
- Application in disease modeling and drug screening.
Main Results
- Successfully generated electrically active sympathetic neurons.
- Demonstrated high efficiency in neuron differentiation.
- Provided a platform for studying cardiac tissue regulation.
- Enabled potential applications in regenerative medicine.
Conclusions
- This protocol offers a stable method for generating sympathetic neurons.
- It can significantly advance research on autonomic disorders.
- The derived neurons have potential applications in various biomedical fields.
Frequently Asked Questions
What are sympathetic neurons?
Sympathetic neurons are part of the autonomic nervous system and are involved in the body's fight-or-flight response.
How long does it take to generate these neurons?
The protocol allows for the generation of electrically active neurons within 20 days.
What are the applications of these neurons?
They can be used for disease modeling, drug screening, and regenerative medicine.
What conditions are suitable for neuron derivation?
The method is conducted under feeder-free culture conditions to enhance scalability.
Can these neurons be used for cardiac tissue studies?
Yes, they can be utilized in co-culture systems to study cardiac tissue regulation.
Executive Industry Relevance
This protocol enables scalable, reproducible generation of functional human postganglionic sympathetic neurons under feeder-free, chemically defined conditions, addressing key bottlenecks in autonomic nervous system disease modeling. By eliminating cell sorting and reducing variability, it supports consistent electrophysiological readouts for target validation and mechanistic de-risking in early discovery. The system provides a disease-relevant human cellular platform for studying sympathetic dysfunction in cardiovascular, metabolic, and neurodegenerative disorders, enhancing translational continuity from target identification to preclinical assessment.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in human-derived sympathetic neurons with validated norepinephrine synthesis and electrical activity.
- Operational Value: Eliminates need for cell sorting, reducing cost and variability while increasing throughput for target engagement studies.
- Predictive Value: Supports mechanistic de-risking by confirming neuronal identity through marker expression (Sox10, Hox6-9) and pharmacological modulation via nicotine and propranolol.
Screening & Assay Development
- Assay Readiness: Produces electrically active neurons by day 20, enabling functional readouts for compound screening in autonomic disorder models.
- Scalability & Reproducibility: Feeder-free, chemically defined conditions allow expansion of neural spheroids for up to two weeks, supporting assay standardization across teams.
- Quantitative Output: Electrophysiological recording provides measurable neuronal firing rates modulated by autonomic agonists and antagonists.
Translational & Preclinical Research
- Disease Modeling: Generates human postganglionic sympathetic neurons relevant to modeling autonomic neuropathies, hypertension, and heart failure.
- Preclinical Continuity: Spheroid expansion capability enables longitudinal studies and dose-response testing in a disease-relevant system.
- Risk-Adjusted Advancement: Functional maturation and drug responsiveness support go/no-go decisions based on target-mediated physiological effects.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing a scalable source of human sympathetic neurons for target validation, progressing to assay development and preclinical evaluation of autonomic targets.
- Discovery Biology: Supports hypothesis testing via genetic (Sox10, Hox6-9) and functional (electrophysiological) validation of neuronal identity and pathway activity.
- Screening: Enables assay-ready neuronal cultures with consistent maturation and drug-responsive electrical activity for compound library screening.
- Analytics: Electrophysiological measurements offer quantitative, functional readouts to assess compound effects on neuronal firing and autonomic modulation.
- Translational Research: Disease-relevant human neuronal model supports biomarker alignment and mechanistic insight into sympathetic disorders.
- Enterprise Reuse: Feeder-free, defined conditions allow platform reuse across multiple targets and projects, reducing redevelopment effort.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through electrically active, marker-verified human sympathetic neurons.
- Operational Value: Standardized, reproducible differentiation eliminates sorting steps and reduces batch variability.
- Strategic Value: Improved go/no-go decisions via functional autonomic readouts, reducing late-stage failure risk in CNS and cardiovascular programs.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on human-relevant sympathetic neuron phenotypes.
Implementation Considerations
- Requires expertise in stem cell culture, neural differentiation, and electrophysiology.
- Dependent on vitronectin-coated plates, basement membrane matrix, and defined media (E8, differentiation, spheroid, and sympathetic neuron media).
- Needs standardization of spheroid formation and splitting procedures across users for reproducibility.
- Adaptation to other autonomic neuron subtypes may require modulation of retinoic acid and timing.
- Limited to in vitro modeling; does not replace in vivo validation of autonomic drug effects.
Biopharma FAQs
Why does electrophysiological recording matter for target validation?
Electrophysiological recording detects neural activity from day 20, confirming functional maturation of differentiated sympathetic neurons. This activity can be enhanced by nicotine and suppressed by propranolol, providing pharmacological validation of neuronal identity and target engagement.
How does spheroid expansion support discovery pipeline scalability?
Intermediate sympathetic neural progenitors can be maintained as neural spheroids for up to two weeks, allowing culture expansion without loss of differentiation potential. This enables scalable production of neurons for screening and target validation campaigns.
What quantitative measurements enable compound screening in this model?
Electrophysiological recording provides measurable neuronal firing rates that respond to autonomic modulators like nicotine and propranolol. These functional readouts allow quantitative assessment of compound effects on sympathetic neuron activity.
Why are replication requirements important for cross-functional collaboration?
The feeder-free, chemically defined protocol reduces variability and eliminates cell sorting, improving reproducibility across laboratories and teams. Consistent marker expression (Sox10, Hox6-9) and functional responses support reliable data sharing in discovery projects.
What statistical analysis is needed before implementing this model in screening?
Implementation requires baseline characterization of neuronal firing rates and dose-response profiles to pharmacological agents like nicotine and propranolol. Establishing these statistical parameters ensures robust detection of compound-induced changes in neuronal activity during screening.
Chapters in this video
0:04
Introduction
0:50
Human Pluripotent Stem Cell (hPSC) Maintenance
1:48
hPSC Differentiation (Day 0)
3:34
Neural Crest Cell (NCC) Induction (Day 1-10)
4:02
NC Spheroid Aggregation (Day 10)
5:14
NC Spheroid Maintenance and Sympathetic Progenitor Induction (Day 11-14)
6:09
Sympathetic Neuron (symN) Differentiation and Maturation (Day 14-20 or 28-35)
7:38
Results: Representative NC Induction, Maintenance, and Expansion
9:43
Conclusion
